Investment Bank for the Healthcare Sector
With insights and relationships throughout the healthcare ecosystem, our team excels at securing ideal partners to create value for our clients.
70
healthcare transactions in 2022
60%
healthcare sell-side M&A transactions with private equity clients in 2022
Providing Quality Outcomes for Healthcare Clients
Healthcare is one of the most dynamic and complex areas in the global economy. Healthcare leaders who want to capitalize on rapid changes in science, regulation, technology and therapeutics benefit from the expertise of investment banking advisors with relevant experience and a keen focus on their unique goals. Our passion for healthcare and our focus on creating shareholder value for our clients has made us one of the fastest growing investment banking advisors for healthcare sector.
Sector Focus
Provider Services
Home Healthcare
Physician Services
Outpatient Services
Pharmacy Services
Pharmaceutical & Lab Services
Contract Research Organizations
Analytical Lab Services
Clinical Lab Services
Contract Manufacturing
Medical Communications
Process Outsourcing
Hospital Outsourcing
Revenue Cycle Management
Employer Health Services
Healthcare IT
Medical Devices & Outsourcing
Devices & Equipment
Products & Supplies
Medical Components
Contract Design / Manufacturing
Life Sciences
Diagnostic Instruments
Research Equipment
Lab Supplies
Consumables & Kits
Managed Care
Health Plans
Third-Party Administration
Benefits Management
Payor Outsourced Services
Perspectives & Publications

Real Deals | Healthcare M&A Resilience
What trends have you seen in the last quarter in relation to valuations in the healthcare space? Matthew Lee: It’s early days to get an accurate read on valuations as… Read More

Scrip | What Does 2023 Hold for Biopharma? Part 6: Artificial Intelligence
Originally posted by Scrip on February 10, 2023. Tony Crisman, Managing Director in Lincoln’s Healthcare Group, shares his predictions for artificial intelligence in the biopharma industry. View the original article.

Scrip | What Does 2023 Hold for Biopharma?
Originally posted by Scrip on January 9, 2023. Tony Crisman, Managing Director in Lincoln’s Healthcare Group, shares his predictions for biopharma mergers and acquisitions (M&A) trends in 2023. View the… Read More

What’s Old is New Again: Value-Based Care Delivery in the Home
In 1930, physicians visiting patients in their residences represented 40 percent of all encounters. 20 years later this figure had fallen dramatically to just one visit in 10. By the… Read More
Lincoln’s expertise in healthcare services and with private companies, combined with their process execution capabilities, proved to be invaluable. At all times the Lincoln team acted as a trusted advisor and truly understood the needs of an owner-entrepreneur."
Recent Transactions in Healthcare
American & European Healthcare Group Heads

I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Dirk-Oliver Löffler
Managing Director | Management Board Member
FrankfurtMeet our Senior Team with Healthcare Expertise

I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Dirk-Oliver Löffler
Managing Director | Management Board Member
Frankfurt